OptimizeRx (OPRX) announced the appointment of Steve Silvestro, currently serving as the Company’s Chief Executive Officer, to its Board of Directors, effective as of June 20, 2025.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OPRX:
- OptimizeRx Stockholders Approve Key Governance Proposals
- OptimizeRx price target raised to $16 from $12.50 at Stifel
- OptimizeRx Earnings Call: Positive Growth and Strategic Shifts
- OptimizeRx price target raised to $18 from $13 at B. Riley
- OptimizeRx price target raised to $22 from $16 at Roth Capital